MedTrace Logo

Meta-analysis of 46 FDA Identified Studies on Lipid Markers

NCT03468127 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1

Last updated 2018-03-16

No results posted yet for this study

Summary

The FDA have revised the data on soy and concluded that a heart health claim is no longer justified based on more recent studies. They are allowing and established panel for public input. The selected studies have not been meta-analyzed, therefore we will conduct a meta-analysis of the 46 FDA selected studies to assess the effect of soy protein on surrogate markers of cardiovascular disease (LDL-C and TC).

Conditions

Interventions

OTHER

Soy foods

Isolated soy protein, soy protein, soybean products, soy milk

Sponsors & Collaborators

  • University of Toronto

    lead OTHER

Principal Investigators

  • David J Jenkins, MD, PhD, DSc · University of Toronto

  • John L Sievenpiper, MD, PhD, FRCPC · University of Toronto

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-03-07
Primary Completion
2018-04-19
Completion
2018-05-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03468127 on ClinicalTrials.gov